BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 23635817)

  • 1. Immunohistochemical staining for p16 is a useful adjunctive test in the diagnosis of Bowen's disease.
    Harvey NT; Leecy T; Wood BA
    Pathology; 2013 Jun; 45(4):402-7. PubMed ID: 23635817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical intraepidermal keratinocytic lesions falling short of carcinoma in situ (Bowen disease) on routine staining: the utility of p16 immunostaining.
    Ko C; Srisuttiyakorn C
    J Cutan Pathol; 2014 Dec; 41(12):975-7. PubMed ID: 25558038
    [No Abstract]   [Full Text] [Related]  

  • 3. The diagnostic value of p63, p16, and p53 immunohistochemistry in distinguishing seborrheic keratosis, actinic keratosis, and Bowen's disease.
    Nasiri S; Azhari V; Bidari-Zerehpoosh F; Asadi-Kani Z; Talebi A
    Dermatol Ther; 2021 Mar; 34(2):e14817. PubMed ID: 33497503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16 immunostaining in keratinocytic neoplasia in organ transplant recipients: Bowen's disease shows a characteristic pattern.
    Genders RE; Beck S; Bouwes Bavinck JN; van den Munckhof HA; Kouwenhoven ST; de Koning MN; de Gruijl FR; Jenkins D; Willemze R; Quint KD
    J Cutan Pathol; 2017 Jan; 44(1):28-33. PubMed ID: 27717097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-67 and p16 Immunostaining Differentiates Pagetoid Bowen Disease From "Microclonal" Seborrheic Keratosis.
    Bahrani E; Sitthinamsuwan P; McCalmont TH; Pincus LB
    Am J Clin Pathol; 2019 May; 151(6):551-560. PubMed ID: 30852607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease.
    Bagazgoitia L; Cuevas J; Juarranz A
    J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):228-30. PubMed ID: 19515076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
    Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas.
    Wrone DA; Yoo S; Chipps LK; Moy RL
    Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Immunohistochemical Localization of Fatty Acid Binding Protein 5 in Actinic Keratosis Compared with That in Bowen's Disease: A Retrospective Study.
    Ahn B; Kim CH; Chae YS; Lee JH; Lee Y; Ahn HH; Lee YJ
    Am J Dermatopathol; 2021 May; 43(5):356-361. PubMed ID: 33055535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
    Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
    J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16INK4a expression in actinic keratosis and Bowen's disease.
    Salama ME; Mahmood MN; Qureshi HS; Ma C; Zarbo RJ; Ormsby AH
    Br J Dermatol; 2003 Nov; 149(5):1006-12. PubMed ID: 14632806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal highlights: Clonal seborrheic keratoses often demonstrates p16 expression.
    Omman RA; Speiser J; Robinson S; Lapadat R; Mudaliar K
    J Cutan Pathol; 2019 Jun; 46(6):411-417. PubMed ID: 30828837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.
    Talghini S; Halimi M; Baybordi H
    Pak J Biol Sci; 2009 Jun; 12(12):929-33. PubMed ID: 19777788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characteristics of human papillomavirus expression and cell proliferation in actinic keratosis and Bowen's disease of the skin.
    Kvlividze O; Gogiashvili L; Burkadze G
    Georgian Med News; 2006 Jul; (136):108-12. PubMed ID: 16905862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of p16 and pRb expression with HPV detection in Bowen's disease.
    Willman JH; Heinz D; Golitz LE; Shroyer KR
    J Cutan Pathol; 2006 Sep; 33(9):629-33. PubMed ID: 16965338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermoscopy of actinic keratosis, intraepidermal carcinoma and squamous cell carcinoma.
    Zalaudek I; Argenziano G
    Curr Probl Dermatol; 2015; 46():70-6. PubMed ID: 25561209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aneuploidy in actinic keratosis and Bowen's disease--increased risk for invasive squamous cell carcinoma?
    Biesterfeld S; Pennings K; Grussendorf-Conen EI; Böcking A
    Br J Dermatol; 1995 Oct; 133(4):557-60. PubMed ID: 7577583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P16(INK4A) expression in Bowen's disease and Bowenoid papulosis.
    Auepemkiate S; Thongsuksai P; Boonyaphiphat P
    J Med Assoc Thai; 2006 Sep; 89(9):1460-5. PubMed ID: 17100385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phasor-FLIM as a Screening Tool for the Differential Diagnosis of Actinic Keratosis, Bowen's Disease, and Basal Cell Carcinoma.
    Luo T; Lu Y; Liu S; Lin D; Qu J
    Anal Chem; 2017 Aug; 89(15):8104-8111. PubMed ID: 28661125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.